Delivery Order SPE2DB22D1017-SPE2DB24FG4EW

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTAQ 400 MG TABLET 60S. The award ceiling value is $10,587.09 and the ultimate completion date is April 20, 2023. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,504,610 MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of August 20, 2024 and a ceiling value of $8,771.60. It is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $88,743.35, is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of February 12, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a $3,956.52 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of August 7, 2024 and was awarded on August 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTAQ 400 MG TABLET 60S. The award, valued at $6,430.35, has an ultimate completion date of April 27, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $14,336.14. The contract has a firm fixed price pricing type and an ultimate completion date of September 19, 2024. This order is a component of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTAQ 400 MG TABLET 60S. The award, valued at $30,199.64, has a period of performance through September 18, 2024 and is a firm fixed price contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,430.70, is for the delivery of MULTAQ 400 MG TABLET 60S, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of November 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a $13,456.14 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of July 31, 2024 and does not have a set-aside designation. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) has awarded a $2,038.48 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MULTAQ 400 MG TABLET 60S, a prescription medication. The award has an ultimate completion date of October 10, 2024 and does not include a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG4EW
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of MULTAQ 400 MG TABLET 60S. The delivery order, valued at $1,937.34, is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. This contract vehicle allows the DLA to efficiently procure a wide range of pharmaceutical and medical supplies from AmerisourceBergen to support military treatment programs and facilities worldwide. The delivery order has a firm fixed-price pricing type and is scheduled for completion by August 30, 2024. The contract is not designated as a set-aside.

Generated 11/28/24, 9:31 AM